{"id":"https://openalex.org/W2393033556","doi":null,"title":"A new atypical antipsychotic drug:lurasidone","display_name":"A new atypical antipsychotic drug:lurasidone","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2393033556","mag":"2393033556"},"language":"en","primary_location":{"id":"mag:2393033556","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XYYL201107026","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2393033556"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046726081","display_name":"LI Huan-fen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101741","display_name":"Henan Psychiatric Hospital","ror":"https://ror.org/015qzwq73","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210101741"]},{"id":"https://openalex.org/I80626142","display_name":"Henan Medical University","ror":"https://ror.org/038hzq450","country_code":"CN","type":"education","lineage":["https://openalex.org/I80626142"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"LI Huan-fen","raw_affiliation_strings":["The Second Affiliated Hospital of Xinxiang Medical University,Xinxiang HE-NAN 453002,China)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Xinxiang Medical University,Xinxiang HE-NAN 453002,China)","institution_ids":["https://openalex.org/I4210101741","https://openalex.org/I80626142"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046726081"],"corresponding_institution_ids":["https://openalex.org/I4210101741","https://openalex.org/I80626142"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13454","display_name":"Phenothiazines and Benzothiazines Synthesis and Activities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.843999981880188},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonism","display_name":"dopamine D2 receptor antagonism","score":0.9869999885559082},{"id":"https://openalex.org/keywords/5-ht2a-receptor-antagonism","display_name":"5-HT2A receptor antagonism","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8410000205039978},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.9911915063858032},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.8812258839607239},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6436983346939087},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5772689580917358},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5336153507232666},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5034245848655701},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4758857488632202},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.455003023147583},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.428947389125824},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23474329710006714}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2393033556","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=XYYL201107026","pdf_url":null,"source":{"id":"https://openalex.org/S2764853906","display_name":"Chinese Journal of New Drugs and Clinical Remedies","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323986928","host_organization_name":"Zhongguo Yao Xuehui Shanghai Fenhui","host_organization_lineage":["https://openalex.org/P4323986928"],"host_organization_lineage_names":["Zhongguo Yao Xuehui Shanghai Fenhui"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of New Drugs and Clinical Remedies","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2022808342","https://openalex.org/W2336961040","https://openalex.org/W2143525518","https://openalex.org/W1969594359","https://openalex.org/W1495807100","https://openalex.org/W2058362354","https://openalex.org/W1907592623","https://openalex.org/W2361166289","https://openalex.org/W2029343515","https://openalex.org/W2043326331"],"abstract_inverted_index":{"Lurasidone":[0],"is":[1,36,49,77,85],"an":[2],"atypical":[3],"antipsychotic":[4],"agent":[5],"belonging":[6],"to":[7,61,71],"benzoisothiazol":[8],"derivatives.It":[9],"was":[10],"approved":[11],"by":[12],"the":[13,34,52,65,81,96],"U.S.Food":[14],"and":[15,45,80],"Drug":[16],"Administration(FDA)":[17],"for":[18,51],"treatment":[19,53],"of":[20,28,41,54,68,98,113],"schizophrenia":[21],"on":[22],"October":[23],"28,":[24],"2010.The":[25],"action":[26],"mechanism":[27],"lurasidone":[29,99,114],"has":[30,58],"been":[31,59],"suggested":[32],"that":[33],"efficacy":[35],"mediated":[37],"through":[38],"a":[39],"combination":[40],"central":[42],"dopamine":[43],"D_2":[44],"5-HT_(2A)":[46],"receptor":[47],"antagonism.Lurasidone":[48],"indicated":[50],"patients":[55],"with":[56,91,95],"schizophrenia.It":[57],"shown":[60],"be":[62,89],"effective":[63],"in":[64,117],"dose":[66,76,84],"range":[67],"40":[69,78],"mg\u00b7d~(-1)":[70,79],"120":[72],"mg\u00b7d~(-1).The":[73],"recommended":[74,83],"starting":[75],"maximum":[82],"80":[86],"mg\u00b7d~(-1).Lurasidone":[87],"should":[88],"taken":[90],"food.Adverse":[92],"reactions":[93],"associated":[94],"use":[97],"may":[100],"include,but":[101],"are":[102,115],"not":[103],"limited":[104],"to,the":[105],"following:":[106],"somnolence,akathisia,nausea,parkinsonism,aud":[107],"agitation.The":[108],"pharmacology,pharmacokinetics,drug":[109],"interactions,clinical":[110],"evaluation,and":[111],"safety":[112],"reviewed":[116],"this":[118],"paper.":[119]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2393033556","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
